Regulatory harmonization is becoming a defining theme in the Japan Clinical Trials Market. By aligning its standards more closely with international benchmarks (like those set by the ICH), Japan is reducing the administrative burden on global companies wishing to launch multi-regional clinical trials. This alignment ensures that high-quality clinical data collected in Japan can be more readily...